Biomarker Elevation in Ovarian Cancer Predicts Poor Prognosis
Category: Innovation & Design · Effect: Strong effect · Year: 2026
Elevated serum levels of Vascular Endothelial Growth Factor (VEGF) are significantly associated with poorer overall survival in ovarian cancer patients.
Design Takeaway
Designers developing medical devices or therapeutic interventions for ovarian cancer should consider incorporating VEGF measurement or targeting as a key feature.
Why It Matters
Understanding the relationship between specific biomarkers and disease outcomes is crucial for developing targeted interventions and improving patient care. This insight highlights the potential for VEGF as a predictive indicator in the design of diagnostic tools and therapeutic strategies.
Key Finding
Higher levels of VEGF in the blood of ovarian cancer patients indicate a worse prognosis, particularly for overall survival, and are linked to more advanced disease.
Key Findings
- Serum VEGF levels were significantly higher in ovarian cancer patients compared to healthy controls.
- Serum VEGF levels were higher in patients with advanced-stage ovarian cancer than in early-stage patients.
- Serum VEGF levels decreased significantly after surgical treatment.
- Elevated serum VEGF levels were significantly associated with poorer overall survival (OS).
- The association between serum VEGF levels and disease-free survival (DFS) was not statistically significant.
Research Evidence
Aim: To assess the relationship between serum VEGF levels and the prognosis of ovarian cancer.
Method: Meta-analysis
Procedure: A comprehensive literature search was conducted across multiple databases to identify studies investigating serum VEGF levels and ovarian cancer prognosis. Data from eligible studies were extracted and analyzed using statistical software to determine the association between VEGF levels and various prognostic indicators, including overall survival and disease-free survival.
Sample Size: 9 studies
Context: Medical diagnostics and oncology
Design Principle
Biomarker correlation with disease progression can inform the design of predictive and prognostic tools.
How to Apply
Incorporate VEGF level assessment into the design of diagnostic assays or as a parameter in predictive models for ovarian cancer.
Limitations
The association with disease-free survival was not statistically significant, suggesting a need for further research to clarify its prognostic value.
Student Guide (IB Design Technology)
Simple Explanation: Measuring a protein called VEGF in the blood can help predict how well someone with ovarian cancer will do.
Why This Matters: This research shows how a specific biological marker can be used to understand and predict the course of a disease, which is vital for designing effective medical solutions.
Critical Thinking: How might the variability in measurement techniques for serum VEGF across different studies affect the reliability of this meta-analysis's conclusions?
IA-Ready Paragraph: Research indicates that elevated serum VEGF levels are a significant indicator of poorer prognosis in ovarian cancer, with a strong association to overall survival. This suggests that VEGF could serve as a critical biomarker in the design of diagnostic and prognostic tools for this disease, guiding the development of more targeted and effective therapeutic strategies.
Project Tips
- When researching medical conditions, look for established biomarkers that correlate with disease severity or patient outcomes.
- Consider how these biomarkers can be integrated into the design of diagnostic tools or treatment plans.
How to Use in IA
- Reference this study when discussing the importance of biomarkers in your design project, especially if your project relates to medical diagnostics or treatment.
Examiner Tips
- Demonstrate an understanding of how scientific research, particularly in medicine, can directly inform design decisions.
Independent Variable: Serum VEGF levels
Dependent Variable: Ovarian cancer prognosis (overall survival, disease-free survival)
Controlled Variables: Stage of ovarian cancer, treatment status (pre/post-surgery)
Strengths
- Comprehensive literature search across multiple databases.
- Inclusion of a significant number of studies for robust analysis.
Critical Questions
- What are the potential mechanisms by which VEGF influences ovarian cancer prognosis?
- Are there specific subtypes of ovarian cancer where VEGF is a more reliable prognostic indicator?
Extended Essay Application
- An Extended Essay could explore the design of a novel diagnostic device that measures serum VEGF levels for early detection or prognosis of ovarian cancer, referencing this meta-analysis for the scientific basis.
Source
Assessment of Serum VEGF Levels in Ovarian Cancer Prognosis: A Meta-Analysis · Clinical and Experimental Obstetrics & Gynecology · 2026 · 10.31083/CEOG44541